About Careers MedBlog Contact us

Stem Cell Transplants More Effective in Treating Severe Multiple Sclerosis

by Dr. Trupti Shirole on February 12, 2015 at 5:03 PM
Font : A-A+

 Stem Cell Transplants More Effective in Treating Severe Multiple Sclerosis

Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), revealed researchers from University of Genova in Italy.

In MS, the body's immune system attacks its own central nervous system (CNS). The study involved 21 people with an average age of 36-years, whose disability due to MS had increased during the last year even though they were taking the first-line of treatment to suppress immune system activity. The participants were at an average disability level where a cane or crutch was needed to walk. During the study period, 12 of the participants received the MS drug mitoxantrone, which reduces immune system activity, while in the other 9 participants, stem cells were harvested from their bone marrow. The stem cells were reintroduced through a vein after suppressing the immune system. Over a time period, the cells migrate to the bone marrow and produce new cells that become immune cells. These participants were followed for up to 4-years.


It was seen that intense immunosupression followed by stem cell treatment reduced disease activity significantly more than the mitoxantrone treatment. Participants who received the stem cell transplants had 80 percent fewer new areas of brain damage called T2 lesions than those who received mitoxantrone, with an average of 2.5 new T2 lesions for those receiving stem cells compared to 8 new T2 lesions for those receiving mitoxantrone. None of the people who received the stem cell treatment had a gadolinium-enhancing lesions during the study, while 56 percent of those taking mitoxantrone had at least one new lesion.

Study author Giovanni Mancardi said, "This process appears to reset the immune system. With these results, we can speculate that stem cell treatment may profoundly affect the course of the disease. The serious side effects that occurred with the stem cell treatment were expected and resolved without permanent consequences. More research is needed with larger numbers of patients who are randomized to receive either the stem cell transplant or an approved therapy, but it's very exciting to see that this treatment may be so superior to a current treatment for people with severe MS that is not responding well to standard treatments."

The study appears online in Neurology, the medical journal of the American Academy of Neurology.

Source: Medindia


Recommended Reading

Latest Genetics & Stem Cells News

 Stem Cell Treatment Resolves Perianal Fistulas in Crohn's Disease
Can stem cell therapy cure fistula? Yes, treatment with stem cells has had a success rate when used in perianal fistulas due to Crohn's Disease.
First Effective Preclinical Models for Most Common Genetic Cause of Leigh Syndrome
In zebrafish models of SURF1 mitochondrial disease, scientists have discovered drugs to prevent neurological decompensation.
Gene Therapy for Rare Eye Disease
New study advances intravitreal gene therapy platform to develop safe and effective therapies for visual loss in Usher Syndrome, rare disorder.
Autism-associated Mutation: New Insights
The study experiments shed light on a rare example of how autism-associated mutation could altered nuclear dynamics.
How Genomic Variants Could Help Diagnose Rare Genetic Disorders
A genotype-first approach to patient care involves selecting patients with specific genomic variants and then studying their traits and symptoms.
View All
open close


Stem Cell Transplants More Effective in Treating Severe Multiple Sclerosis Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests